{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06520826",
            "orgStudyIdInfo": {
                "id": "USRC-2024-001"
            },
            "organization": {
                "fullName": "USRC Kidney Research",
                "class": "NETWORK"
            },
            "briefTitle": "Vafseo Outcomes In-Center Experience",
            "officialTitle": "Safety of Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Hemodialysis Subjects: Vafseo Outcomes In-Center Experience",
            "acronym": "VOICE",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "vafseo-outcomes-in-center-experience"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-22",
            "studyFirstSubmitQcDate": "2024-07-22",
            "studyFirstPostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "USRC Kidney Research",
                "class": "NETWORK"
            },
            "collaborators": [
                {
                    "name": "Akebia Therapeutics",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment of anemia in in-center hemodialysis patients with End Stage Kidney Disease (ESKD). This study will obtain long-term safety data in a large sample of subjects receiving in-center hemodialysis to support adoption of three times per week vadadustat dosing."
        },
        "conditionsModule": {
            "conditions": [
                "Anemia of Chronic Kidney Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 2200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Vadadustat",
                    "type": "EXPERIMENTAL",
                    "description": "Vadadustat, 300 mg tablets, administered orally three times per week",
                    "interventionNames": [
                        "Drug: Vadadustat"
                    ]
                },
                {
                    "label": "Erythropoiesis-stimulating agent (ESA) - Standard of Care (SOC)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Epoetin alfa (EPOGEN), Methoxy polyethylene glycol-epoetin beta (Mircera), or Darbepoetin alfa (Aranesp) administered as per standard of care",
                    "interventionNames": [
                        "Drug: Erythropoiesis Stimulating Agent"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Vadadustat",
                    "description": "A synthetic, orally bioavailable, small molecule being developed as an inhibitor of hypoxia-inducible factor prolyl-hydroxylases for the treatment of anemia associated with chronic kidney disease. Intervention to be administered to maintain hemoglobin within a target range of 10-11 g/dL.",
                    "armGroupLabels": [
                        "Vadadustat"
                    ],
                    "otherNames": [
                        "Vafseo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Erythropoiesis Stimulating Agent",
                    "description": "Standard of care erythropoiesis stimulating agent will be administered to maintain hemoglobin within a target range of 10-11 g/dL.",
                    "armGroupLabels": [
                        "Erythropoiesis-stimulating agent (ESA) - Standard of Care (SOC)"
                    ],
                    "otherNames": [
                        "Epoetin alfa (EPOGEN), Methoxy polyethylene glycol-epoetin beta (Mircera), or Darbepoetin alfa (Aranesp)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "All-cause mortality",
                    "timeFrame": "18 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "All-cause hospitalization",
                    "timeFrame": "18 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients greater than or equal to 18 years of age.\n* Receiving outpatient in-center hemodialysis at least three times per week for end-stage kidney disease.\n* Currently prescribed or eligible for erythropoiesis-stimulating agent based on approved facility policy\n* Understands the procedures and requirements of the study and provides written informed consent and authorization for protected health information disclosure.\n\nExclusion Criteria:\n\n* Contraindication to receive vadadustat or any of its known constituents per the United States Prescribing Information (USPI) as determined by the treating clinician.\n* Concomitant use of any hypoxia-inducible factor prolyl-hydroxylases or probenecid.\n* Unable to comply with study requirements or in the opinion of the treating physician or Investigator, not clinically stable to participate in the study.\n* Pregnant at time of consent (per subject self-report).",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Stephanie Brillhart, MSCI",
                    "role": "CONTACT",
                    "phone": "3038819451",
                    "email": "stephanie.brillhart@usrenalcare.com"
                },
                {
                    "name": "Martha Block, RN, CCRP",
                    "role": "CONTACT",
                    "phone": "7205912533",
                    "email": "martha.block@usrenalcare.com"
                }
            ],
            "locations": [
                {
                    "facility": "USRC Kidney Research",
                    "city": "Lone Tree",
                    "state": "Colorado",
                    "zip": "80124",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.55171,
                        "lon": -104.8863
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                },
                {
                    "id": "D000000740",
                    "term": "Anemia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4070",
                    "name": "Anemia",
                    "asFound": "Anemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "asFound": "Chronic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068817",
                    "term": "Epoetin Alfa"
                },
                {
                    "id": "D000068256",
                    "term": "Darbepoetin alfa"
                },
                {
                    "id": "D000006397",
                    "term": "Hematinics"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M314",
                    "name": "Epoetin Alfa",
                    "asFound": "Distance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M244",
                    "name": "Darbepoetin alfa",
                    "asFound": "Small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M207501",
                    "name": "Chrysarobin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4854",
                    "name": "Benzocaine",
                    "relevance": "LOW"
                },
                {
                    "id": "M9485",
                    "name": "Hematinics",
                    "asFound": "Investigates",
                    "relevance": "HIGH"
                },
                {
                    "id": "T433",
                    "name": "Tannic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}